Immunocore Holdings (IMCR) Enterprise Value (2021 - 2026)

Immunocore Holdings has reported Enterprise Value for 8 years, with the latest figure at -$844.9 million in Q1 2026.

• Quarterly Enterprise Value fell 0.94% year-over-year to -$844.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$844.9 million (down 0.94% YoY) and the FY2025 annual result came in at -$864.2 million, down 5.34% from the prior year.
• Enterprise Value advanced to -$844.9 million in Q1 2026 per IMCR's latest filing, from -$864.2 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$262.0 million in Q2 2022 and troughed at -$901.3 million in Q3 2024.
• A 5-year average of -$690.5 million and a median of -$834.9 million in 2024 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value slumped 100.66% in 2024, then climbed 0.99% in 2025.
• Over 5 years, Enterprise Value stood at -$390.0 million in 2022, then declined by 13.48% to -$442.6 million in 2023, then slumped by 85.34% to -$820.4 million in 2024, then slipped by 5.34% to -$864.2 million in 2025, then climbed by 2.23% to -$844.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$844.9 million, -$864.2 million, and -$892.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.